key: cord-0036041-kcpoaeva authors: Krueger, Gerhard R. F.; Wagner, Mathias; Chandrasekhar, Chitra title: Pathology of the Gastrointestinal Tract date: 2012-11-27 journal: Atlas of Anatomic Pathology with Imaging DOI: 10.1007/978-1-4471-2846-5_4 sha: 1ceabc796f5be674931466df34cde881810025e3 doc_id: 36041 cord_uid: kcpoaeva This chapter presents representative photographs of common diseases in the esophagus, stomach, small and large intestines, appendix, and rectum. Most of the diseases discussed here are infectious or neoplastic; a few others appear that students should be able to identify. A few microscopic photographs are added to support the understanding of gross lesions. This chapter presents representative photographs of common diseases in the esophagus, stomach, small and large intestines, appendix, and rectum. Most of the diseases discussed here are infectious or neoplastic; a few others appear that students should be able to identify. A few microscopic photographs are added to support the understanding of gross lesions. Esophageal diseases present clinically with a combination of dysphagia, pain (heartburn), and vomiting. Most common are esophageal re fl ux disease (erosive esophagitis of different stages) with recurrent in fl ammation and eventual focal intestinal metaplasia of the mucosa (Barrett's esophagus). Shown is another form of erosive and ulcerative esophagitis caused by infection with human cytomegalovirus (HCMV). Barrett's esophagus is at risk of developing into adenocarcinoma of the esophagus. Besides HCMV esophagitis, another form of infectious esophagitis is shown, which is caused by invasive Candida (fungal) infection. Both are frequently seen in immunode fi cient patients with malignant tumors, leukemia, AIDS, or certain forms of inherited immune de fi ciency syndromes. The most common tumors are squamous cell carcinoma and adenocarcinoma. Other changes shown here are found in patients with chronic liver diseases, such as esophageal varices in liver cirrhosis and portal hypertension. Portal hypertension follows obstruction of portal blood fl ow, most commonly in the liver (e.g., in cirrhosis); it also may be prehepatic (e.g. , portal vein thrombosis) or posthepatic (e.g., Budd-Chiari syndrome, occlusion of the hepatic vein and tributaries). It is characterized by ascites, splenomegaly, and varices in the stomach, esophagus, and skin (caput medusa) following the opening up of portosystemic collateral veins. Of patients with cirrhosis of the liver and uncorrected portal hypertension, the initial acute hemorrhage used to kill 50 % of the patients. Of those remaining, another 50 % died of the second hemorrhage. Early diagnosis of portal hypertension and surgical correction of blood fl ow blockages are the treatment of choice a b As in the esophagus, most diseases in the stomach are in fl ammatory (infectious) or neoplastic. Not discussed here are congenital diseases and hernias. In fl ammatory diseases (various forms of gastritis) may follow circulatory changes, autoimmune disorders, or infection (e.g., Helicobacter pylori gastritis). Shown here are congestive gastritis following severe right heart failure, erosive gastritis in Helicobacter infection, pseudomembranous gastritis in agranulocytosis, various kinds of gastric ulcers, and gastritis in autoimmune disease (e.g., scleroderma). Most important are the various presentations of gastric neoplasias, including adenocarcinoma and primary malignant lymphoma. Acute and chronic gastritis differ both etiologically and morphologically. Among their causes are infection (e.g., H. pylori ), chemical injury (aspirin, nonsteroidal antiin fl ammatory drugs [NSAIDs], alcohol, steroids), autoimmunity, and circulatory changes (stress, sepsis, shock). Acute gastritis is commonly erosive, hemorrhagic, or both, whereas chronic gastritis ranges from a mild, super fi cial form or lymphocytic gastritis with autoantibodies (autoimmune gastritis in pernicious anemia) to severe, atrophic gastritis with intestinal metaplasia and increased risk of gastric cancer. Peptic ulcer disease refers to mucosal ulcerations in the stomach and duodenum resulting from various causes, such as gastritis related to consumption of alcohol, aspirin, and NSAIDs. It appears that psychic and genetic in fl uences in these patients are responsible for excessive gastric secretions of hydrochloric acid and peptic enzymes. Shown here is a typical, sharply de fi ned gastric ulcer located in the "magenstrasse" (the major route of food transport in the lesser curvature). More common are peptic ulcers in the upper duodenum and pyloric area [ 2 ] . More details of their diagnosis, classi fi cation, clinical features, and prognosis may be found in major textbooks of pathology and clinical specialties. Fig. 4 .33 Hemorrhagic infarction. Sudden occlusion of a large artery by embolism or thrombosis leads to hemorrhagic infarction. Less frequently, hemorrhagic infarction may be caused by autoimmune arteritis. Thrombosis of mesenteric veins causes ischemia without overt infarction because of good collateral blood fl ow, unless small veins are also occluded. The fi gure shows a typical hemorrhagic infarction of the small intestine. Note the segmental hyperemia with subsequent segmental hemorrhagic enteritis and necrosis. Microscopy shows hyperemia, edema, mucosal hemorrhage, and eventual necrosis. Muscular dysfunction will cause ileus and subsequent peritonitis and shock In severe cases, more extensive mucosal damage will cause pseudomembranous enteritis. Other common infectious organisms causing this type of enteritis are Yersinia , Campylobacter species, and the more toxic Clostridium perfringens Fig. 4 .44 Crohn's disease. Enteritis regionalis (Crohn's disease) is a chronic in fl ammatory disease preferentially of the small bowel. Its cause is not known, but its pathogenesis is thought to be infectiousautoimmune. Crohn's disease starts with edematous thickening of the intestinal wall, lymphoid in fi ltrates, and focal granulomas and fi stulas progressing to mucosal atrophy, fi brosis, and eventual perforation and peri-intestinal mesenteric in fl ammation. There is prominent regional lymphadenopathy. ( a , b ) Atrophy and fi brosis of the bowel mucosa and wall, with typical pseudopolypoid mucosal hyperplasia (cobblestone mucosal surface with intermittent fi stulas) Fig. 4.71 ( a , b ) Severe, diffuse, hemorrhagic, and necrotizing colitis with intestinal paralysis (paralytic ileus) following infection with toxic E. coli organisms (enterohemolytic E. coli ). Note the dark purple color and prominent dilatation of the large bowel. The disease is also known as toxic megacolon a b Fig. 4.72 ( a , b ) Necrotizing putrid colitis with gas formation (gas gangrene, Gasbrand ) following infection with C. perfringens . Note the focal ulcers covered by pseudomembranes ( brownish areas ) and multiple intramural gas bubbles with a glassy appearance. The yellowbrownish color of this specimen results from formalin fi xation Fig. 4 .73 Focal necrotizing colitis with perforation. In a patient with myeloblastic leukemia and agranulocytosis, the usual colitis (as in Fig. 4 .61 ) progressed to ulceration and perforation (formalin-fi xed specimen) Ulcerative colitis. Ulcerative colitis is a chronic, recurrent ulcerative disease of the large intestine. Although it is idiopathic, its pathogenesis appears to include several factors, such as genetic predisposition, infection, and autoimmunity. It is occasionally associated with other autoimmune disorders, such as primary sclerosing cholangitis, erythema nodosum, systemic vasculitis, and uveitis. Tests for autoantibodies (perinuclear antineutrophil cytoplasmic antibodies) are frequently positive in ulcerative colitis. The disease usually starts with a yellowish exudate and hyperemia of the proctosigmoid mucosa and the left-sided colon, but it may extend to involve the entire colon (pancolitis). Ulcerative colitis progresses with recurrent attacks and the formation of extensive, coalescent ulcerations with islands of intact mucosa in between. Fulminant cases may show features of toxic megacolon (see Fig. 4 .71 ). Radiologic features are shown in Fig. 4 .64 . This fi gure and Fig. 4 .75 show typical gross pathologic changes of ulcerative colitis in the colon, with segmental severe in fl ammation with con fl uent ulcerations The clinical term polyp consists of various pathologic entities, essentially of reactive lesions and of neoplastic growths. Reactive types are hyperplastic, in fl ammatory, hamartomatous, and juvenile polyps. Neoplastic polyps are known in pathology as adenomas (adenomatous polyps) or polypoid carcinomas. Adenomas are subclassi fi ed according to their proliferative activity and their structure as tubular adenomas, villous adenomas, and mixed tubulovillous adenomas. The risk of malignant transformation to carcinoma rises with the prolifera-tive activity, that is, from tubular to villous adenoma. This pedunculated tubular adenoma of the large intestine ( a ) was removed by endoscopy. Microscopy shows proliferation of nonatypical tubular glands ( b , c ), resulting in classi fi cation as an adenomatous polyp-that is, a tubular adenoma (benign). In a villous adenoma ( d , e ), the gross surface would not be smooth but would look velvety; microscopy shows an irregular, fi ne villous surface with a hyperplastic and often dysplastic epithelium Transformation into adenocarcinoma is a stepwise process from usually benign precursor lesions, involving the altered activation of proto-oncogenes and repressor genes as well as defective repair mechanisms. Grossly, adenocarcinoma of the colon is classi fi ed as polypoid, ulcerative, or in fi ltrative. The prognosis depends on the spread of the tumor through the colonic wall and metastases into lymph nodes and more distant organs (especially the liver). Shown in this fi gure is a common ulcerated, primary adenocarcinoma of the colon and rectum. Note the elevated fi rm wall with immobile mucosa surrounding an irregular and partially bloody ulcer focal, constrictive lesion of the colon producing a circumferential "apple core" deformity in the sigmoid colon Food-related illness and death in the United States Bethesda: National Cancer Institute